// App-Quantinova.ai

2729 : Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Primary Results from a Phase 3 Trial

Researchers

Presenter

  • Desiree van der Heijde

Principal Investigators

  • Lianne Gensler

  • Tae-Hwan Kim

  • Walter P. Maksymowych

  • Mikkel astergaard

  • Denis Poddubnyy

  • Helena Marzo-Ortega

  • Louis Bessette

  • Tetsuya Tomita

  • Gaia Gallo

  • David Adams

  • Ann Leung

  • Fangyi Zhao

  • Maja Hojnik

  • Hilde Carlier

  • Joachim Sieper

Medical Centers

  • Oregon Health and Science University, Portland, OR

  • Leiden University Medical Centre, Leiden, Netherlands

  • University of California, San Francisco, CA

  • Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea

  • University of Alberta, Edmonton, AB, Canada

  • Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark

  • Charité – Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany

  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, Leeds, Leeds, United Kingdom

  • Laval University, Quebec, Quebec, Canada.

  • Osaka University Graduate School of Medicine, Suita, Japan

  • Eli Lilly and Company, Indianapolis, IN

  • Syneos Health, Raleigh, NC

  • Eli Lilly and Company, Indianapolis, IN

  • Charite Universitaetsmedizin Berlin, Medical Oncology, Berlin, Germany

Locations

  • United States

  • Netherlands

  • Canada

  • Denmark

  • Germany

  • United Kingdom

  • Japan

  • Republic of South Korea

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Non-radiographic axial spondyloarthritis

  • Sacroiliitis

  • Axial spondyloarthritis

Biomarkers

  • C reactive protein

Drug/Treatment

  • LY2439821

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved